Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2

Author:

Noguchi Shinzaburo,Masuda Norikazu,Iwata Hiroji,Mukai Hirofumi,Horiguchi Jun,Puttawibul Puttisak,Srimuninnimit Vichien,Tokuda Yutaka,Kuroi Katsumasa,Iwase Hirotaka,Inaji Hideo,Ohsumi Shozo,Noh Woo-Chul,Nakayama Takahiro,Ohno Shinji,Rai Yoshiaki,Park Byeong-Woo,Panneerselvam Ashok,El-Hashimy Mona,Taran Tetiana,Sahmoud Tarek,Ito Yoshinori

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference30 articles.

1. American Cancer Society. Global cancer facts & figures. 2nd ed. Atlanta: American Cancer Society; 2011.

2. WHO. World Health Organization fact sheet no 297. Feb 2012. http://www.who.int/mediacentre/factsheets/fs297/en/index.html . Accessed 19 Mar 2012.

3. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol. 2005;34:405–12.

4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version I.2012. Available at: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf . Accessed 19 Mar 2012.

5. Dodwell D, Wardley A, Johnston S. Postmenopausal advanced breast cancer: options for therapy after tamoxifen and aromatase inhibitors. Breast. 2006;15:584–94.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3